Genetics Generation Advancement Corp. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 547.81 million compared to TWD 519.51 million a year ago.

Net income was TWD 25.73 million compared to TWD 7.84 million a year ago. Basic earnings per share from continuing operations was TWD 1.0117 compared to TWD 0.3054 a year ago. Diluted earnings per share from continuing operations was TWD 1.0021 compared to TWD 0.3054 a year ago.